Canada markets open in 6 hours 25 minutes

Sutro Biopharma, Inc. (S09.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.16000.0000 (0.00%)
As of 03:29PM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 244.25M
Enterprise Value -21.84M
Trailing P/E 82.31
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.34
Price/Book (mrq)2.83
Enterprise Value/Revenue 0.19
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.24
52-Week Change 3-23.48%
S&P500 52-Week Change 324.71%
52 Week High 35.4500
52 Week Low 31.9100
50-Day Moving Average 33.7236
200-Day Moving Average 33.5646

Share Statistics

Avg Vol (3 month) 35
Avg Vol (10 day) 3N/A
Shares Outstanding 581.79M
Implied Shares Outstanding 682.07M
Float 860.39M
% Held by Insiders 10.92%
% Held by Institutions 173.07%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024


Profit Margin -74.61%
Operating Margin (ttm)-435.05%

Management Effectiveness

Return on Assets (ttm)-17.01%
Return on Equity (ttm)-81.12%

Income Statement

Revenue (ttm)154.06M
Revenue Per Share (ttm)2.53
Quarterly Revenue Growth (yoy)2.60%
Gross Profit (ttm)N/A
EBITDA -96.67M
Net Income Avi to Common (ttm)-114.96M
Diluted EPS (ttm)-1.7500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)313.22M
Total Cash Per Share (mrq)3.83
Total Debt (mrq)28.07M
Total Debt/Equity (mrq)28.64%
Current Ratio (mrq)4.46
Book Value Per Share (mrq)1.57

Cash Flow Statement

Operating Cash Flow (ttm)-115.37M
Levered Free Cash Flow (ttm)-31.49M